Literature DB >> 6375391

Growth of human squamous head and neck cancer in vitro.

M A Cobleigh, P A Gallagher, J H Hill, E L Applebaum, W P McGuire.   

Abstract

This study was undertaken to define the cloning efficiency of squamous head and neck (H/N) cancer in soft agar. Twenty squamous cell carcinomas of H/N origin were mechanically dissociated and cultured in the human tumor clonogenic assay ( HTSCA ). No growth was observed. Nine ascites specimens from separate patients with ovarian cancer were cultured during the same time period, and six grew, all with more than 30 colonies per plate. Thirty-one additional H/N specimens were enzymatically dissociated and cultured in the HTSCA . Again, no growth was observed. Sixteen of these enzymatically dissociated specimens were simultaneously cultured in identical media without agar. Five specimens grew. We conclude that squamous carcinoma of H/N requires anchorage and fibroblast support for successful growth in culture. Suspension in semisolid media is less effective than liquid tissue culture systems for in vitro growth of this tumor type.

Entities:  

Mesh:

Year:  1984        PMID: 6375391      PMCID: PMC1900523     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

1.  EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY.

Authors:  J R TENNANT
Journal:  Transplantation       Date:  1964-11       Impact factor: 4.939

2.  The clonal assay of head and neck tumor cells: results and clinical correlations.

Authors:  M E Johns
Journal:  Laryngoscope       Date:  1982-07       Impact factor: 3.325

3.  In vitro stem cell assay in head and neck squamous carcinoma.

Authors:  D E Mattox; D D Von Hoff
Journal:  Am J Surg       Date:  1980-10       Impact factor: 2.565

4.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

5.  The poor cloning ability in agar of human tumour cells from biopsies of primary tumours.

Authors:  H T Rupniak; B T Hill
Journal:  Cell Biol Int Rep       Date:  1980-05

6.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

7.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.

Authors:  D D Von Hoff; J Casper; E Bradley; J Sandbach; D Jones; R Makuch
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

  7 in total
  5 in total

1.  Reconstituted basement membrane (Matrigel): a useful semisolid medium for growth of tumor cell colonies.

Authors:  N Oridate; R Lotan; D Lotan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

2.  Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors.

Authors:  R J Tatake; N Rajaram; R N Damle; B Balsara; A N Bhisey; S G Gangal
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 3.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.

Authors:  G H Boerrigter; E C Heinerman; B J Braakhuis; G B Snow
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

Review 5.  Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Authors:  Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur
Journal:  Cancers (Basel)       Date:  2015-08-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.